Susan Hasty, Publisher
Table of Contents . . . February 17th, 1997Non-Subscriber - Summaries Only
Conference Coverage (Retrovirus) - Disappointing Results With Vaccine/AZT Combination
Conference Coverage (Retrovirus) - Naked-DNA HIV Vaccine Safe in First Human Trials
Conference Coverage (Retrovirus) - New Paradigm For AIDS Therapies: Prevent Drug Resistance
Conference Coverage (Retrovirus) - New Tricks For Old Vaccine
Conference Coverage (Retrovirus) - Routine Vaccination Does Not Affect HIV
Conference Coverage (Retrovirus) - Two P or Not Two P: That Is The Question
AIDS Therapies - Drugs Helping, But Doubts Linger
AIDS Therapies - Therapy Partly Rebuilds Damaged Immune System
AIDS Therapies (Clinical Trials) - Six-Month Results of HIV Trial Announced
AIDS Therapies (Combination Therapy) - Options Remain Open for Patients Treated with Drug Combination
AIDS Therapies (Drug Combination) - Nevirapine and Protease Inhibitor "Cocktails" Are Safe for HIV Patients
AIDS Therapies (ISIS 5320) - Phase I Clinical Trials Begin of Anti-HIV Compound
AIDS Therapies (Invirase) - Drug Studied in Combination with Three Protease Inhibitors
AIDS Therapies (PHT) - Passive Hyperimmune Therapy Treatment Ownership Reaffirmed
AIDS Therapies (Remune) - Increased Chemokine Production Observed with Treatment
HIV Testing - Lawmakers Seek To Curb Prostitution In Kansas City
Industry News (Acquisitions) - Pharmacies Partner with CCA To Implement HIV Program
Industry News (HIV Testing) - Product Development Collaboration Entered To Develop Test
Industry News (Joint Ventures) - Research Agreements Announced To Participate in Trials
Industry News (Patents and Technology) - Patent Filed Using Immune System Cells To Fight Disease
Industry News (Therapy) - Collaboration Announced For HIV/AIDS Therapy
International (Africa) - Zimbabwe Orders AIDS/HIV Tests for Rape Victims
International (Asia) - HIV Cases Jump Ten Percent in Hong Kong in 1996
International (Europe) - First-Line Approval Received for Abelcet in Spain
Legal Issues - Hospital Won't Appeal Award To Patient Raped By Another
Obstetrics (Fertility/Infertility) - HIV Risk in Discordant Couples Seeking to Conceive
Pathogenesis (HIV) - Extent of Virus Replication In Vivo Is Major Determinant of Pathogenicity
Pathogenesis (HIV) - Primary Immune Response Predicts Disease Progression
TB/HIV Coinfection - TB Incidence Among HIV+ Higher in Eastern U.S.
TB/HIV Coinfection - Two-Step TB Testing Useful in HIV+
Transmission - Disease Control Programs Should Apply 20/80 Rule
Antisense Therapy (HIV) - "Better Protection Against HIV Infection by Dual Function Retroviral Vectors."
Drug Resistance (Antiviral) - "HIV Resistance To Protease Inhibitor."
Hematopoietic Gene Therapy (HIV) - "Suitability of Bone Marrow from HIV-1 Infected Donors for Retroviral-Mediated Gene Transfer."
Occupational Risk (Prophylaxis) - "Infection Control and Post-Exposure Prophylaxis."
Occupational Risk (Virus Transmission) - "Occupational Exposure to Blood and Body Fluids among Health Care Workers in Australia."
Opportunistic Infections - "Trends in CD4 Count at Diagnosis of HIV Related Opportunistic Infections and Malignancies."
Prophylaxis (HIV) - "Vaccination for the Person with HIV Infection."
HTLV/HIV Coinfection - "Retroviral Coinfections at a New Orleans HIV Outpatient Clinic."
Immunology - "A New Class of Antigen-Specific Killer Cells."
Kaposi's sarcoma (KSHV) - "Detection of the Herpesvirus-Like DNA Sequences in Matched Specimens of Semen and Blood from Patients with AIDS-Related Kaposi's sarcoma by Polymerase Chain Reaction in situ Hybridization."
Kaposi's sarcoma (KSHV) - "Propagation of a Human Herpesvirus from AIDS-Associated Kaposi's sarcoma."
Long-Term Non Progressors - "Hemophilia and Nonprogressing Human Immunodeficiency Virus Type 1 Infection."
Prostitution (HIV) - "HIV-1 Infection among Female Commercial Sex Workers in Rural Thailand."
Transmission (HIV) - "Male Circumcision and Susceptibility to HIV Infection among Men in Tanzania."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.